InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
4.230
-0.120 (-2.76%)
Nov 20, 2024, 4:00 PM EST - Market closed
InMed Pharmaceuticals Market Cap
InMed Pharmaceuticals has a market cap or net worth of $2.82 million as of November 21, 2024. Its market cap has increased by 101.73% in one year.
Market Cap
2.82M
Enterprise Value
-1.74M
1-Year Change
101.73%
Ranking
Category
Stock Price
$4.23
Market Cap Chart
Since November 16, 2020, InMed Pharmaceuticals's market cap has decreased from $26.00M to $2.82M, a decrease of -89.14%. That is a compound annual growth rate of -42.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 3.00M | 36.36% |
| Dec 29, 2023 | 2.20M | 15.79% |
| Dec 30, 2022 | 1.90M | -89.73% |
| Dec 31, 2021 | 18.50M | -19.57% |
| Dec 31, 2020 | 23.00M | -11.54% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TNF Pharmaceuticals | 2.92M |
| Lipella Pharmaceuticals | 2.91M |
| Avenue Therapeutics | 2.88M |
| NuCana | 2.88M |
| Theriva Biologics | 2.86M |
| CareMax | 2.82M |
| Sintx Technologies | 2.78M |
| Silexion Therapeutics | 2.77M |